SCHEMBL1491665

SCHEMBL1491665

NC(=O)ONc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.45
GAA P10253 2/20 0.45
GFER P55789 1/20 0.45
TSHR P16473 4/20 0.44
ALDH1A1 P00352 3/20 0.44
TP53 P04637 2/20 0.44
KMT2A Q03164 2/20 0.44
CASP3 P42574 2/20 0.44
SENP7 Q9BQF6 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
PKM P14618 2/20 0.44
EPHX1 P07099 1/20 0.44
EPHX2 P34913 1/20 0.44
CDK9 P50750 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
HSD17B10 Q99714 3/20 0.41
TYR P14679 1/20 0.41
TAS2R38 P59533 1/20 0.41
NAPRT Q6XQN6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27360366 0.81 NAPRT (0.50) MAPTGAATSHRALDH1A1TP53
SCHEMBL27558551 0.81 TSHR (0.48) MAPTGAATSHRALDH1A1TP53
SCHEMBL8863134 0.81 TSHR (0.48) MAPTGAATSHRALDH1A1TP53
SCHEMBL28080823 0.78 L3MBTL1 (0.44) MAPTGAAGFERTSHRALDH1A1
SCHEMBL27807620 0.77 ALDH1A1 (0.52) MAPTGAATSHRALDH1A1TP53
SCHEMBL3271953 0.77 TSHR (0.44) GAATSHRALDH1A1TP53KMT2A
SCHEMBL4766156 0.77 NAPRT (0.52) MAPTGAATSHRALDH1A1TP53
SCHEMBL11685657 0.77 KMT2A (0.44) MAPTGAATSHRALDH1A1TP53
SCHEMBL11038625 0.76 ALDH1A1 (0.43) MAPTGAATSHRALDH1A1TP53
SCHEMBL28812358 0.76 NAPRT (0.50) MAPTGAATSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109310060-A For the composition of Weeds distribution, external member and method 维德奥特有限公司 2019-02-05 CN disclosed
CN-109265400-A Arginine methyltransferase inhibitor and application thereof EPIZYME股份有限公司 2019-01-25 CN disclosed
CN-108884054-A For treating the compound of proliferative diseases 儿童医学中心公司 2018-11-23 CN disclosed
CN-105339351-B Arginine methyltransferase inhibitors and uses thereof EPIZYME股份有限公司 2018-11-06 CN disclosed
CN-108623743-A The method of big gas ammonia is reduced with multi-anion copolymer and containing the seed products of multi-anion copolymer 沃戴申生命科学有限责任公司 2018-10-09 CN disclosed
CN-108472617-A Include the microcapsules of polyester-urethane shell and hydrophilic nuclear material 巴斯夫欧洲公司 2018-08-31 CN disclosed
CN-108472616-A Include the microcapsules of polyester-urethane shell and hydrophobic nuclear material 巴斯夫欧洲公司 2018-08-31 CN disclosed
CN-105873966-B Fertilizer with polyanionic polymers and method for applying polyanionic polymers to plants 沃戴申生命科学有限责任公司 2018-05-01 CN disclosed
CN-105849142-B Acroleic acid polyurethane composite resin particle 关西涂料株式会社 2018-03-23 CN disclosed
CN-107568214-A A kind of pesticidal solid Nanodispersion and preparation method thereof 中国农业科学院农业环境与可持续发展研究所 2018-01-12 CN disclosed
EP-1879895-B1 ENZYME INHIBITORS CHROMA THERAPEUTICS LTD (GB) 2011-06-08 EP disclosed
US-7939666-B2 Enzyme inhibitors CHROMA THERAPEUTICS LTD. (GB) 2011-05-10 US disclosed
EP-2301939-A1 Enzyme inhibitors Chroma Therapeutics Limited (GB) 2011-03-30 EP disclosed
US-20090291978-A1 Enzyme Inhibitors CHROMA THERAPEUTICS LTD. (GB) 2009-11-26 US disclosed
CN-101133060-A Enzyme inhibitors CHROMA THERAPEUTICS LTD (GB) 2008-02-27 CN disclosed
EP-1879895-A1 ENZYME INHIBITORS Chroma Therapeutics Limited (GB) 2008-01-23 EP disclosed
WO-2006117549-A1 ENZYME INHIBITORS CHROMA THERAPEUTICS LTD (GB) 2006-11-09 WO disclosed
CN-1250549-C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands HOFFMANN LA ROCHE (CH) 2006-04-12 CN disclosed
CN-1483034-A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands - 2004-03-17 CN disclosed
US-3979202-A Meta-bifunctional benzenes and herbicidal compositions MONSANTO COMPANY (US) 1976-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291978-A1 Enzyme Inhibitors HAT1, NR2E1, NR2C2 MAPT 4873/4885GAA 3209/4885GFER 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.